DOWNS-SYNDROME - TRANSIENT ABNORMAL MYELOPOIESIS AND ACUTE-LEUKEMIA

被引:10
作者
BAIN, B
机构
[1] Department of Haematology, St. Mary's Hospital Medical School, London
关键词
DOWNS SYNDROME; ABNORMAL MYELOPOIESIS; ACUTE LEUKEMIA;
D O I
10.3109/10428199109070274
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Subjects with Down's syndrome have an increased risk, particularly during childhood, of developing acute leukaemia. There is an increased incidence both of acute lymphoblastic leukaemia and of acute myeloid leukaemia (AML), particularly acute megakaryoblastic leukaemia, often presenting with the clinical features of acute myelofibrosis. In addition neomates with Down's syndrome show a high incidence of polycythaemia and may also develope a syndrome simulating acute leukaemia, commonly designated transient abnormal myelopoiesis (TAM). Although TAM closely resembles acute leukaemia there are some subtle differences and infants who survive four to eight weeks usually show a complete remission. Subsequently a significant proportion of these infants develop AML usually around the age of 2 to 3 years. Cytogenetic evidence indicates that in at least some neonates with TAM the abnormal cells are monoclonal. The presence of a cytogenetically abnormal clone is not incompatible with subsequent complete remission with loss of the abnormal close and long survival. For these reasons it may be justifiable to regard TAM as transient acute myeloid leukaemia. Although other lineages are also involved in TAM the blast cells are usually predominantly megakaryoblasts. This, together with the predominance of megakaryoblastic leukaemia among cases of AML in Down's syndrome, suggests that abnormal proliferation of megakaryoblasts in specifically linked to the presence of a supernumerary chromosome 21. Further support for this hypothesis is provided by cases of TAM in subjects with mosaicism for trisomy 21 or for a related abnormality of chromosome 21; the abnormal proliferating cells are derived from the cytogenetically abnormal population. Additional factors are clearly necessary for the occurrence of TAM or AML in subjects with Down's syndrome but their nature is as yet unknown. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:309 / &
相关论文
共 60 条
[1]  
Fong C., Brodeur G.M., Down’s syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis, Cancer Genetics and Cytogenetics, 28, pp. 55-76, (1987)
[2]  
Rosner F., Lee S.L., Down’s syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature, American Journal of Medicine, 53, pp. 203-218, (1972)
[3]  
Fabia J., Drolette M., Malformations and leukemia in children with Down’s syndrome, Pediatrics, 45, pp. 60-70, (1970)
[4]  
Lewis D.S., Thompson M., Hudson E., Liberman M.M., Samson D., Down’s syndrome and acute megakaryoblastic leukaemia. Case report and review of the literature, Acta Haematologica, 70, pp. 236-242, (1983)
[5]  
Zipursky A., Peeters M., Poon A., Megakaryoblastic leukemia and Down’s syndrome: a review, Pediatric Hematology and Oncology, 4, pp. 211-230, (1987)
[6]  
Robinson L.L., Nesbit M.E., Sather H.N., Level C., Shahidi N., Kennedy A., Hammond D., Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study Group, Journal of Pediatrics, 105, pp. 235-242, (1984)
[7]  
Nakagawa T., Nishida H., Arai T., Yamada T., Fukuda M., Sakamota S., Hyperviscosity syndrome with transient abnormal myelopoiesis in Down syndrome, Journal of Pediatrics, 112, pp. 58-61, (1988)
[8]  
Bessho F., Hayashi Y., Hayashi Y., Ohga K., Ultrastructural studies of peripheral blood of neonates with Down’s syndrome and transient abnormal myelopoiesis, American Journal of Clinical Pathology, 88, pp. 627-633, (1988)
[9]  
Suda J., Eguchi M., Akiyama Y., Iwama Y., Furukawa T., Sata Y., Miura Y., Suda T., Saito M., Differentiation of blast cells from a Down’s syndrome patient with transient myeloproliferative disorder, Blood, 69, pp. 508-512, (1987)
[10]  
Wong K.Y., Jones M.M., Srivastava A.K., Gruppo R.A., Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndrome, Journal of Pediatrics, 112, pp. 18-22, (1988)